Baseline characteristics of HSES/LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of overall population. حسب Krystal Hunter (6820052)

الموضوعات:

Diagram of study population. حسب Krystal Hunter (6820052)

الموضوعات:

A representative participant performing a Valsalva maneuver while checking the real-time respiratory pressure indicator. حسب Eun-Seon Yang (19751340)

الموضوعات:

Raw data. حسب Saeedeh Abbasi (9423189)

الموضوعات:

Data. حسب Saeedeh Abbasi (9423189)

الموضوعات:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. حسب Jiefeng Zhao (9090305)

الموضوعات:

Determination of Cleaved Caspase-3 positive cells in MTA and Harvard treated groups. حسب Meltem Karahan (19713246)

الموضوعات:

Dose-dependent effect of dental materials on hatching rate of zebrafish embryos and larvae at the indicated time points. حسب Meltem Karahan (19713246)

الموضوعات:

Dose-dependent effect of dental materials on the survival of zebrafish embryos and larvae at the indicated time points. حسب Meltem Karahan (19713246)

الموضوعات:

The apoptic effects of dental materials on zebrafish larvae. حسب Meltem Karahan (19713246)

الموضوعات:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. حسب Masashi Okawa (8951294)

الموضوعات:

The characteristics and clinical features of 12 patients. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. حسب Masashi Okawa (8951294)

الموضوعات:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. حسب Masashi Okawa (8951294)

الموضوعات:

The original data for the figures. حسب Masashi Okawa (8951294)

الموضوعات:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)

الموضوعات:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات: